Skip to main content

PGT-M conditions

This table shows all PGT-M conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact

Download full approved condition list.

Condition name Status OMIM number Documents
Prion disease with protracted course approved 606688
Progressive External Opthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant 3 (PEOA3) approved 609286
Progressive Familial Intrahepatic Cholestasis Type 1 (PFIC1) approved 211600
Prolidase Deficiency approved 170100
Propionic Acidemia approved 606054
Pseudoachondroplasia approved 177170
Pseudohypoparathyroidism (PHP1a) approved 103580
Pseudo-TORCH syndrome-type 1 approved 251290
Pseudo-TORCH syndrome-type 2 approved 617397
Pseudovaginal Perineoscrotal Hypospadias due to 5-Alpha-Reductase Deficiency (insofar as that condition affects males, with simultaneous sex determination) approved 264600
Pyogenic Arthritis, Pyoderma Gangrenosum and Acne Syndrome (PAPA) approved 604416
Pyrodoxine-dependent seizures (EPD) approved 266100
Pyruvate dehydrogenase E1-alpha deficiency X-linked approved 312170
Pyruvate Dehydrogenase E1-beta Deficiency approved 614111
Pyruvate Dehydrogenase, Alpha-1 (PDHA1) approved 312170
Radioulnar synostosis with amegakaryocytic thrombocytopenia type 1 (RUSAT1) approved 605432
Radioulnar synostosis with amegakaryocytic thrombocytopenia type 2 (RUSAT2) approved 616738
Rapp-Hodgkin Syndrome (RHS) approved 129400
Recurrent Digynic Triploidy approved
Recurrent hydatidiform mole (HYDM1) approved 231090